Abstract
A Pandemic devastates the life of global citizens and causes significant economic, social, and political disruption. Evidence suggests that Pandemic’s likelihood has increased over the past century because of increased global travel and integration, urbanization, and changes in land use. Further, evidence concerning the urban character of the Pandemic has underlined the role of cities in disease transmission. An early assessment of the severity of infection and transmissibility can help quantify the Pandemic potential and prioritize surveillance to control of urban areas in Pandemics. In this paper, an Urban Vulnerability Assessment (UVA) methodology is proposed. UVA investigates the possible vulnerable factors related to Pandemics to assess the vulnerability in urban areas. A vulnerability index is constructed by the aggregation of multiple vulnerability factors computed on each urban area (i.e., urban density, poverty index, informal labor, transmission routes). UVA provides insights into early vulnerability assessment using publicly available data. The applicability of UVA is shown by the identification of high-vulnerable areas where surveillance should be prioritized in the COVID-19 Pandemic in Bogotá, Colombia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No additional funding was granted for writing this paper.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No medical data from external sources is used in this paper. Data comprised public information about demographic, transportation, socio-economic, and health conditions reported from 2011 to 2020 of Bogotá, Colombia. Public information was obtained from the National Department of Statistics (DANE), from District Planning Secretary of Bogotá (SDP), and District Mobility Secretary of Bogotá (SDM). DANE: - https://www.dane.gov.co/files/comunicados/Nota_metodologica_indice_de_vulnerabilidad.pdf - https://www.dane.gov.co/files/investigaciones/condiciones_vida/pobreza/2018/bt_pobreza_multidimensional_18.pdf - http://microdatos.dane.gov.co/index.php/catalog/643 SDP: - http://www.sdp.gov.co/sites/default/files/determinantes_de_la_distribucion_espacial_de_informalidad_laboral_en_bogota.pdf - http://www.sdp.gov.co/gestion-estudios-estrategicos/informacion-cartografia-y-estadistica/repositorio-estadistico/monografia-de-bogota-2017\%5D - http://www.sdp.gov.co/gestion-estudios-estrategicos/informacion-cartografia-y-estadistica/repositorio-estadistico/monografia-de-bogota-2011\%5D SDM: - http://www.sdp.gov.co/sites/default/files/determinantes_de_la_distribucion_espacial_de_informalidad_laboral_en_bogota.pdf